RenovoRx Inc. is a biopharmaceutical company that focuses on the development and commercialization of innovative targeted therapies for the treatment of solid tumors. Their proprietary technology, RenovoGem, combines chemotherapy with localized therapy to enhance tumor response and minimize side effects. With a strong pipeline and a commitment to improving patient outcomes, RenovoRx is poised for success in the oncology market.
